The risk of bronchiolitis obliterans syndrome is reduced in lung transplant patients who receive mycophenolate mofetil based immunosuppression
J.M Dunitz, M.I Hertz, S.K Savik, S.J ParkVolume:
22
Year:
2003
Language:
english
DOI:
10.1016/s1053-2498(02)00934-8
File:
PDF, 51 KB
english, 2003